Glucagon-like peptide-1 receptor agonists and glycemic management in non-critical hospitalized patients
10.3760/cma.j.cn311282-20221201-00669
- VernacularTitle:胰升糖素样肽-1受体激动剂在非危重住院患者血糖管理中的作用
- Author:
Mingyu LIU
1
;
Jia LI
Author Information
1. 中国人民解放军南部战区总医院内分泌科，广州 510010
- Keywords:
Glucagon-like peptide-1;
Glucagon-like peptide-1 receptor agonists;
Glycemic management;
Non-critical hospitalized patients
- From:
Chinese Journal of Endocrinology and Metabolism
2023;39(5):460-466
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, with the continuous development of glucagon-like peptide-1 receptor agonists(GLP-1RA), its role in the management of blood glucose in hospitalized patients has been explored. GLP-1RA can not only control blood glucose in non-critically ill hospitalized patients, but also inhibit appetite, delay gastric emptying, protect nerves, anti-inflammation, reduce systolic blood pressure and blood lipids. At the same time, many studies have found that it can also improve cardiovascular and renal outcomes and reduce the risk of hospitalization complications. Therefore, this paper analyzes the role of GLP-1RA in glycemic management by reviewing domestic and international studies, consensus and guidelines related to inpatient blood glucose management, and helps to better manage blood glucose of patients in non-critical care setting.
